Interim analyses of a phase I study with GSK2857916, an antibody–drug conjugate against B cell maturation antigen, have previously reported a 60% overall response and 7.9 months progression-free ...
SAN CARLOS, Calif., March 20, 2019 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced new clinical data on APX005M will be presented at the American ...
SEATTLE, March 20, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology, autoimmune and hematology therapeutics, announced ...
ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) announced in a news release it will present data in support of its new antibody candidates for Parkinson's disease, at the 2019 Alzheimer's & Parkinson ...
SUZHOU, China, March 18, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX:01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines ...
Selected for podium presentation: novel antibody candidates bind only the toxic species of alpha-synuclein offering potential advantages over less selective therapies in development In the March 31 ...
COLUMBUS , Ohio Cancer immunologists here have discovered how a protein on the surface of antibody-making immune cells boosts the amount of antibody the cells make. The protein, called CD86, is ...
Antibodies are large Y-shaped proteins. They are recruited by the immune system to identify and neutralize foreign objects like bacteria and viruses. Each antibody has a unique target known as the ...
ROCKVILLE, Md., March 19, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in ...
COLUMBUS , Ohio A new study suggests that antibody-based cancer drugs might help patients more if they are given with substances that stimulate the immune system. The drug trastuzumab consists of an ...
Paris (AFP) - An antibody taken from an Ebola survivor has been found to target all three human strains of the virus and could eventually lead to an all-purpose vaccine against the killer disease, ...